Navigation Links
FDA Approves the NovoTTF-100A System for the Treatment of Patients With Recurrent Glioblastoma Multiforme (GBM) Brain Tumors
Date:4/15/2011

WASHINGTON, April 15, 2011 /PRNewswire/ -- Novocure today announced that the U.S. Food and Drug Administration (FDA) approved the NovoTTF-100A System (NovoTTF) for the treatment of adult patients with glioblastoma multiforme (GBM) brain tumors, following tumor recurrence after receiving chemotherapy.  The portable, wearable device delivers an anti-mitotic, anti-cancer therapy as patients maintain their normal daily activities. The NovoTTF is a novel, first-in-class treatment option for patients and physicians battling glioblastoma.  

(Photo:  http://photos.prnewswire.com/prnh/20110415/CG83483-a)

(Photo:  http://photos.prnewswire.com/prnh/20110415/CG83483-b)

"Our device provides patients and physicians with a novel, non-invasive alternative to chemotherapy that is safe and effective," said Eilon Kirson, M.D., Ph.D., Novocure's Chief Medical Officer.  "The device allows for continuous treatment without the usual, debilitating side effects that chemotherapies inflict on recurrent GBM patients and indirectly on their families."

Results from a 237 patient randomized pivotal trial demonstrated that compared to patients treated with chemotherapy,  NovoTTF treated patients achieved comparable median overall survival times, had fewer side effects, and reported improved quality of life scores.

Glioblastoma is the most aggressive and most common form of primary brain tumor in the United States.  The disease affects approximately 10,000 Americans each year.  The median overall survival time from initial diagnosis is 15 months with optimal therapy, and median survival from the time of tumor recurrence is only three to four months without additional effective treatment.  The disease is widely recognized as one of the most aggressive and deadly
'/>"/>

SOURCE Novocure
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Approves Horizant To Treat Restless Legs Syndrome
2. FDA Approves New Treatment for Rare Form of Thyroid Cancer
3. FDA Approves Special Protocol Assessment for Phase 3 Trial of Polaris Groups Cancer Therapeutic, ADI-PEG 20, in the Treatment of Hepatocellular Carcinoma
4. FDA Approves Hyperopia Application for the MEL 80 Excimer Laser from Carl Zeiss Meditec
5. FDA Approves New Treatment for a Type of Late-Stage Skin Cancer
6. FDA Approves Zostavax Vaccine to Prevent Shingles in Individuals 50 to 59 Years of Age
7. FDA Approves Gadavist for Central Nervous System Scans
8. U.S. FDA Approves Bayers Gadavist™ (Gadobutrol) Injection for MRI of the Central Nervous System
9. FDA Approves Device to Maintain Blood Flow During Artery Bypass Brain Surgery
10. FDA Approves BENLYSTA® for Lupus in Breakthrough for Millions of Sufferers
11. FDA Approves Revised Alphanate® Labeling to Include Reduced Infectivity of an Experimental Model Agent for vCJD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... CHAPEL HILL, N.C. , May 22, 2015 ... is critical to pharmaceutical brand recognition and success. ... Practices, LLC conducted a study to provide pharmaceutical ... level of investment (FTEs and budget) that are ... companies. Pharmaceutical and biotech marketing managers can utilize ...
(Date:5/22/2015)... , May 22, 2015 The ... in 2014 and is estimated to reach $90.7 million by ... Browse through the TOC of North America Dental ... with the help of various tables and figures. ... 10% customization on this report.   Dental ...
(Date:5/22/2015)... -- The Mesothelioma Victims Center is incredibly passionate about ... best possible compensation, and they are also extremely focused ... caused by exposure to asbestos or their family ... options such as a recent possible medical breakthrough. For ... anytime at 866-714-6466. http://MesotheliomaVictimsCenter.Com ...
Breaking Medicine Technology:Effective Marketing Services Group Critical for Pharmaceutical Brand Recognition 2North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 2North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 5
... Benefits Including Stress Reduction, Pain Relief and Improved Sleep ... According to the American Medical Association, stress is a ... The World Health Organization cites stress as America,s No. ... stress a "major health problem." An Arizona entrepreneur, however, ...
... Body mass index (BMI) should be taken into account ... researchers at Cancer Treatment Centers of America ... lower levels of vitamin D compared to non-obese patients. , ... , , The association between vitamin D and obesity ...
Cached Medicine Technology:Scottsdale Facility to Be First in U.S. to Showcase True REST Technology 2Scottsdale Facility to Be First in U.S. to Showcase True REST Technology 3Researchers Say More Aggressive Vitamin D Supplementation Needed in Obese Cancer Patients 2
(Date:5/22/2015)... Pasadena, Calif. (PRWEB) May 22, 2015 ... where technology, communication and capacity are intersecting to ... and across society, the opening speaker at WesternU's ... , California Lieut. Gov. Gavin Newsom, a former ... was the keynote speaker at the graduation ceremony ...
(Date:5/22/2015)... 22, 2015 The American College of ... in June. They will hold a webinar on the ... two-day class on Classical Chinese Medicine. , Webinar – ... Steve Given, the Dean of Clinical Education, will lead ... First Professional Doctorate program. ACTCM is currently developing this ...
(Date:5/22/2015)... OH (PRWEB) May 22, 2015 River ... that Kyle Johnson, the health system’s Chief Financial Officer ... interests. Johnson has served as the company CFO since ... West will be joining the health system as CFO. ... an interim basis, while the Board of Trustees conducts ...
(Date:5/22/2015)... Following yesterday’s announcement that Ascenta Health ... health brand Nature’s Way, Marc St-Onge has affirmed his ... Skin is an integral part of the agreement with ... to further develop Ascenta Skin into a leading player ... a breakthrough, anti-aging skincare supplement featuring 6 active ingredients ...
(Date:5/22/2015)... Combination therapy, or polytherapy, will ... obstructive pulmonary disorder (COPD) as the dominant companies ... as well as Germany’s Boehringer Ingelheim compete with ... will market payers, clinicians and patients be disposed ... completely new ones? , In spite of recently ...
Breaking Medicine News(10 mins):Health News:Newsom to WesternU Grads: The Future is Inside You 2Health News:Newsom to WesternU Grads: The Future is Inside You 3Health News:ACTCM Announces Upcoming June Events 2Health News:River Valley Health Partners Announces CFO Transition, Appointment of Interim CFO 2Health News:Ascenta Skin President Announces Plans to Grow Brand 2Health News:Chronic Obstructive Pulmonary Disorder Therapeutics Market Discussed in In-demand FirstWord Report Published at MarketPublishers.com 2
... N.C., Sept. 21 Whether it is bragged or whispered about, ... recent study by Adam & Eve shows that for most folks, ... (Photo: http://www.newscom.com/cgi-bin/prnh/20090921/LA79100 ) , , (Logo: ... the most trusted name in adult entertainment, recently asked over 1,000 ...
... ... Traumatic Brain Injury , ... September 21, 2009 -- In the current issue of Molecular Medicine, a team of scientists ... progesterone may be beneficial in protecting the brain after traumatic injury. Traumatic brain ...
... children under 10 will need two doses, preliminary U.S. trial ... who are between 10 and 17 years old will apparently ... according to initial results of ongoing trials, U.S. health officials ... two doses of the new H1N1 vaccine, the officials added. ...
... , SACRAMENTO, Calif., Sept. 21 Former California Assembly ... a Purple Ribbon Panel and Task Force starting work today to ... double among Californians by the year 2030. The state has not ... , Brown will be joined by Lloyd Dean, Jonathan ...
... ... face transplant are offering full details about the research, preparation, actual surgery and current ... ... first near-total face transplant, the surgeons involved are offering full details about the research, ...
... , FORT WASHINGTON, Pa., Sept. 21 A ... LACTAID(R) Brand found that 77 percent of Latinas reduce the amount of ... lactose intolerance. Yet, 63 percent of Latinas who have lactose intolerance ... and vitamins A and D. Despite their concerns, only 14 percent ...
Cached Medicine News:Health News:Adam & Eve's 'Great American Sex Survey' Asks 'How Was YOUR First Time?' 2Health News:News from the Latest Issue of Molecular Medicine 2Health News:1 Swine Flu Shot Enough for Older Kids 2Health News:1 Swine Flu Shot Enough for Older Kids 3Health News:Elaine Alquist, Willie Brown and Kim Belshe Convene Purple Ribbon Panel, Task Force on Alzheimer's 2Health News:Details Emerge About Approach, Results of First US Face Transplant 2Health News:New Research Finds Latinas with Lactose Intolerance Manage Their Condition by Limiting or Avoiding Dairy 2Health News:New Research Finds Latinas with Lactose Intolerance Manage Their Condition by Limiting or Avoiding Dairy 3
Inquire...
... Pectoralis Implants come in three styles. Each ... by far the most popular style. Pectoral ... are packaged and sold individually, not in ... they are each made for a specific ...
... The latest software product in the IQmark ... new, more efficient levels of portability, cost-savings and ... is perfect for use in the office, clinics ... and emergency situations. , ,When used in conjunction ...
... EZ Holter is engineered to set a ... you do is enter the patient demographics, ... ,This three-channel, Windows based system uses the ... accuracy and versatility of the IQmark Holter ...
Medicine Products: